Skip to main content

Table 4 Clinical characteristics of study individuals

From: Novel insights into systemic sclerosis using a sensitive computational method to analyze whole-genome bisulfite sequencing data

 

SSc (N = 9)

Controls (N = 4)

Mean or %

SD or N

Mean or %

SD or N

Age, years

52.8

16.2

37.2

19.8

Female, %

100

9

100

4

Ethnicity, %

    

Caucasian

77.8

7

50

2

Asian

22.2

2

25

1

Other

–

0

25

1

Smoking, %

    

Current

11.1

1

–

0

Past

22.2

2

25

1

Never

55.6

5

75

3

Unknown

11.1

1

–

0

Disease duration, years

10.4

7.0

  

Interstitial lung disease, %

11.1

1

  

Arthritis, %

11.1

1

  

Myositis, %

22.2

2

  

Raynaud’s, %

100

9

  

Anti-nuclear antibodies

    

Titer ≥ 1:80, %

100

9

  

Titer ≥ 1:160, %

66.7

6

  

Titer ≥ 1:640, %

55.6

5

  

Blood biochemical indices

    

C-reactive protein (CRP), mg/L

29.5

65.3¶

  

Erythrocyte sedimentation rate, mm/hr

23.7

14.1

  

Abs. whole blood cell (WBC), K/μL

8.2

4.6

  

Abs. lymphocytes, K/μL

1.6

0.7

  

Abs. monocytes, K/μL

0.7

0.7¶

  

Disease-specific variables

    

Limited skin disease, %

33.3

3

  

Diffuse skin disease, %

66.7

6

  

Immunosuppressive medication§, %

33.3

3

  
  1. ¶Over-dispersion due to extreme values
  2. §Methotrexate or Mycophenolate Mofetil in the past